Market Analysis - ICVI-2017
Market Analysis Report
The Comprehensive virology market is anticipated to evolve in next 10 years since prevalence of pathogenic diseases, growth in discovery of mutating and adapting viruses, and the progressing need for emerging techniques in Medical Virology which is interdisciplinary of Virology/microbiology and pathology. During 2015-2016, the virology industry has been profoundly influenced by contagious viruses such as Ebola, MERS, hepatitis C viruses & zika viruses. By 2017, is dominating the research, with better prospects in the near future, since few important patents are approaching expiry, including Tamiflu, Sustiva, Tenofovir, Combivir, Relenza, and Telbivudine. With the expiry of these blockbuster drugs, the market is estimated to encounter a dynamic competitive landscape. The generic competition in the virology market will be in this high pace from 2017 onward. The Americas commanded the largest share and Europe is projected to maintain the position as the second largest market globally. During the forecast periods, America and Europe is anticipated to record the highest CAGR, governed by enhanced healthcare infrastructure, access to diagnostics, and enhanced affordability of diagnostic tests for viral diseases.
Cancer Immunology & Oncolytic Virology market (2011-2018)
· The global cancer Cancer Immunology & Oncolytic Virology market reached nearly $29.00 billion in 2011. This market is expected to grow to $67.90 billion in 2018 with a compound annual growth rate (CAGR) of 14.7%.
· The USA market for Cancer Immunology & Oncolytic Virology market reached nearly $14.00 billion in 2011. It is further projected to grow to nearly $30.7 billion in 2018 with a CAGR of 15.0% over the five-year period, 2013 to 2018.
· The European market for Cancer Immunology & Oncolytic Virology market reached nearly $7.9 billion in 2011. It is further projected to grow to nearly $14.4 billion in 2018 with a CAGR of 10.5%.
Scope of Cancer Immunology & Oncolytic Virology market
Cancer Immunology & Oncolytic Virology market provides an overview of the current and potential global market for cancer immunotherapy and virology. It identifies the need for more effective drugs for treatment of infectious diseases caused by viruese. This report provides important trends in field, new developments and sales forecasts for Cancer Immunology & Oncolytic Virology from 2011 through 2018. Issues and trends addressed in this report are based on information from industry sources, regulatory and healthcare policies, demographics and other factors that directly affect the cancer market. The report also addresses opportunities for future players.
There is an increasing need for new and innovative drugs. This young industry is experiencing tremendous growth. This field is still in its infancy, showing immense promise for the clinical management of cancer.
Medical Virology-2017 is the premier event that brings together a unique and International mix of experts, researchers and decision makers from both academia and industry across the globe to exchange their knowledge, experience and research innovations. The scope of Medical Virology-2017 is to bring the advancements in the field of Virology and viruses which are of contributing significant global burden of infectious diseases. Medical Virology focuses in particular on the most current research related to the laboratory diagnosis of human and animal infections and the role of the laboratory in both the management of infectious diseases and the elucidation of the epidemiology of infections, the latest developments in Medical Virology and Techniques in Virology, providing the current state of knowledge in the field, as well as balanced, thought-provoking perspectives on controversial issues.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations, video presentations and various programs for participants from all over the world. We invite you to join us at the Medical Virology-2017, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Medical Virology-2017 organizing committee look forward to meet you in America, Philadelphia, Pennsylvania, USA.
Importance and Scope:
Medical Virology-2017 will be the best platform for all the Virologist, Scientists, Research scholars, Students, Technologist who are working in this field to exchange their knowledge related to Medical Virology and Techniques in Virology. This International event is an effort to find an alternative for different new technique against diseases caused by infectious viruses.
Why to attend?
In today's economic climate your business decisions are as crucial as ever. International Conference on Medical virology Summit and Expo allow you to maximize your time and marketing dollars while receiving immediate feedback on your new products and services. International Conference on Medical virology Summit and Expo is organizing an outstanding Scientific Exhibition/Program and anticipates the world's leading specialists involved in Medical Virology and Techniques in Virology. Your organization will benefit with excellent exposure to the leaders in Medical virology Summit and Expo. Medical Virology-2017 is an exciting opportunity to showcase the new technology, the new products of your company, and/or the service your Industry may offer to a broad international audience.